FGFR2 Gene Craniosynostosis Nonspecific Genetic Test
Cost: 4400.0 AED
Test Components:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Dysmorphology
Doctor:
Pediatrics
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for FGFR2 Gene Craniosynostosis, nonspecific NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR2 Gene Craniosynostosis, nonspecific NGS Genetic DNA Test gene FGFR2.
Test Details:
The FGFR2 gene is associated with craniosynostosis, which is a condition characterized by the premature fusion of the bones in the skull. Mutations in the FGFR2 gene can lead to abnormal bone growth and development, resulting in various types of craniosynostosis. Nonspecific NGS genetic testing refers to the use of next-generation sequencing (NGS) technology to analyze multiple genes simultaneously, without targeting a specific gene or condition. This type of testing is often used in cases where the underlying genetic cause is unknown or when there is a suspicion of a genetic disorder but the specific gene(s) involved are uncertain. In the context of craniosynostosis, nonspecific NGS genetic testing can help identify mutations in the FGFR2 gene, as well as other genes that may be associated with craniosynostosis or related conditions. By analyzing multiple genes at once, this testing approach can provide a broader picture of the genetic factors contributing to craniosynostosis. The results of a nonspecific NGS genetic test can help in confirming a diagnosis of craniosynostosis, determining the specific genetic cause, and guiding appropriate management and treatment options. It can also provide valuable information for genetic counseling and family planning.
| Test Name | FGFR2 Gene Craniosynostosis nonspecific Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Dysmorphology |
| Doctor | Pediatrics |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for FGFR2 Gene Craniosynostosis, nonspecific NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR2 Gene Craniosynostosis, nonspecific NGS Genetic DNA Test gene FGFR2 |
| Test Details |
The FGFR2 gene is associated with craniosynostosis, which is a condition characterized by the premature fusion of the bones in the skull. Mutations in the FGFR2 gene can lead to abnormal bone growth and development, resulting in various types of craniosynostosis. Nonspecific NGS genetic testing refers to the use of next-generation sequencing (NGS) technology to analyze multiple genes simultaneously, without targeting a specific gene or condition. This type of testing is often used in cases where the underlying genetic cause is unknown or when there is a suspicion of a genetic disorder but the specific gene(s) involved are uncertain. In the context of craniosynostosis, nonspecific NGS genetic testing can help identify mutations in the FGFR2 gene, as well as other genes that may be associated with craniosynostosis or related conditions. By analyzing multiple genes at once, this testing approach can provide a broader picture of the genetic factors contributing to craniosynostosis. The results of a nonspecific NGS genetic test can help in confirming a diagnosis of craniosynostosis, determining the specific genetic cause, and guiding appropriate management and treatment options. It can also provide valuable information for genetic counseling and family planning. |
